212 related articles for article (PubMed ID: 19796823)
21. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
[TBL] [Abstract][Full Text] [Related]
23. Adverse events after intravitreal triamcinolone in patients with and without uveitis.
Galor A; Margolis R; Brasil OM; Perez VL; Kaiser PK; Sears JE; Lowder CY; Smith SD
Ophthalmology; 2007 Oct; 114(10):1912-8. PubMed ID: 17908594
[TBL] [Abstract][Full Text] [Related]
24. Injection of triamcinolone acetonide into the posterior sub-tenon capsule for treatment of diabetic macular edema.
Toda J; Fukushima H; Kato S
Retina; 2007; 27(6):764-9. PubMed ID: 17621188
[TBL] [Abstract][Full Text] [Related]
25. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study.
Parodi MB; Iacono P; Ravalico G
Br J Ophthalmol; 2008 Aug; 92(8):1046-50. PubMed ID: 18556425
[TBL] [Abstract][Full Text] [Related]
27. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
29. Macular function by multifocal electroretinogram in diabetic macular edema after intravitreal triamcinolone acetonide injection.
Karacorlu M; Ozdemir H; Senturk F; Arf Karacorlu S; Uysal O
Eur J Ophthalmol; 2008; 18(4):601-8. PubMed ID: 18609482
[TBL] [Abstract][Full Text] [Related]
30. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Er H
Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
[No Abstract] [Full Text] [Related]
31. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema.
Dehghan MH; Ahmadieh H; Ramezani A; Entezari M; Anisian A
Int Ophthalmol; 2008 Feb; 28(1):7-17. PubMed ID: 17589809
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
Breusegem C; Vandewalle E; Van Calster J; Stalmans I; Zeyen T
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):573-6. PubMed ID: 18824737
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.
Okhravi N; Morris A; Kok HS; Menezo V; Dowler JG; Hykin PG; Lightman S
J Cataract Refract Surg; 2007 Jul; 33(7):1278-83. PubMed ID: 17586387
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis.
Mihalache A; Hatamnejad A; Patil NS; Popovic MM; Kertes PJ; Cruz-Pimentel M; Muni RH
Ophthalmologica; 2024; 247(1):19-29. PubMed ID: 37579730
[TBL] [Abstract][Full Text] [Related]
36. Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results.
Nomoto H; Shiraga F; Yamaji H; Fukuda K; Baba T; Takasu I; Ohtsuki H
Retina; 2008 Mar; 28(3):427-32. PubMed ID: 18327134
[TBL] [Abstract][Full Text] [Related]
37. Update on treatments for diabetic macular edema.
Fraser-Bell S; Kaines A; Hykin PG
Curr Opin Ophthalmol; 2008 May; 19(3):185-9. PubMed ID: 18408491
[TBL] [Abstract][Full Text] [Related]
38. Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.
Choi KS; Chung JK; Lim SH
Korean J Ophthalmol; 2007 Mar; 21(1):11-7. PubMed ID: 17460426
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal steroids for macular edema in diabetes.
Grover D; Li TJ; Chong CC
Cochrane Database Syst Rev; 2008 Jan; (1):CD005656. PubMed ID: 18254088
[TBL] [Abstract][Full Text] [Related]
40. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial.
Maia OO; Takahashi BS; Costa RA; Scott IU; Takahashi WY
Am J Ophthalmol; 2009 Feb; 147(2):291-297.e2. PubMed ID: 18929352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
